Finance

Lists
4746:TPE
Formosa Laboratories Inc
NT$49.20
-1.60%
(-0.80) 1D
Aug 25, 12:18:19 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 4746...
Open
NT$50.10
High
NT$50.30
Low
NT$48.80
Mkt. cap
5.92B
Avg. vol.
582.01K
Volume
641.70K
Dividend
6.10%
Quarterly dividend
NT$0.75
Ex-dividend date
Aug 24, 2026
P/E ratio
12.54
52-wk high
NT$70.10
52-wk low
NT$48.50
EPS
NT$3.92
Shares outstanding
99.01M
No. of employees
480
Open
NT$50.10
High
NT$50.30
Low
NT$48.80
Mkt. cap
5.92B
Avg. vol.
582.01K
Volume
641.70K
Dividend
6.10%
Quarterly dividend
NT$0.75
Ex-dividend date
Aug 24, 2026
P/E ratio
12.54
52-wk high
NT$70.10
52-wk low
NT$48.50
EPS
NT$3.92
Shares outstanding
99.01M
No. of employees
480
About Formosa Laboratories Inc
CEO-
Employees480
Founded1985
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.16B
1.30B
1.06B
1.11B
Cost of goods sold
668.85M
761.78M
606.66M
677.26M
Cost of revenue
668.85M
761.78M
606.66M
677.26M
Research and development expenses
173.66M
172.00M
186.06M
222.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
139.89M
120.93M
125.15M
120.25M
Operating expense
337.14M
263.70M
306.56M
347.66M
Total operating expenses
1.01B
1.03B
913.22M
1.02B
Operating income
154.63M
278.70M
150.78M
86.13M
Other non operating income
1.54M
-17.06M
741.00K
-116.64M
EBT including unusual items
339.36M
135.78M
50.30M
-25.56M
EBT excluding unusual items
172.06M
279.94M
141.70M
-25.56M
Income tax expense
42.45M
9.70M
35.33M
27.03M
Effective tax rate
12.51%
7.15%
70.25%
-105.76%
Other operating expenses
-
-
-
5.12M
Net income
324.10M
147.32M
18.76M
-14.48M
Net profit margin
27.93%
11.30%
1.76%
-1.30%
Earnings per share
2.68
-
-
-
Interest and investment income
6.68M
8.72M
5.76M
7.90M
Interest expense
-7.10M
-6.43M
-7.07M
-4.72M
Net interest expenses
-416.00K
2.29M
-1.31M
3.18M
Depreciation and amortization charges
-
-
-
-
EBITDA
282.41M
440.33M
290.96M
230.76M
Gain or loss from assets sale
5.01M
-5.19M
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps